Theratechnologies to Present Preclinical Data at AACR

Theratechnologies to Present Preclinical Data at AACR

Data show that sudocetaxel zendusortide (TH1902) can induce tumor infiltrating lymphocytes and potentiate anti-PD-L1 immunotherapy in a melanoma mouse......

Theratechnologies Presents New Tesamorelin Data

Theratechnologies Presents New Tesamorelin Data

Presentation at Conference on Retroviruses and Opportunistic Infections (CROI) demonstrates association between excess visceral abdominal fat (EVAF)......

Theratechnologies to Announce Fourth Quarter and Full Year

Theratechnologies to Announce Fourth Quarter and Full Year

MONTREAL, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on......

menu
menu